Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

By Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 419-426

Elsevier

Access to resources Recommend Favorite

Treatment of Uterine Papillary Serous Carcinoma with Paclitaxel

By Ramondetta L.   Burke T.W.   Levenback C.   Bevers M.   Bodurka-Bevers D.   Gershenson D.M.  

Gynecologic Oncology, Vol. 82, Iss. 1, 2001-07 ,pp. : 156-161

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Uterine Papillary Serous Carcinoma

By Resnik E.   Taxy J.B.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 123-127

Academic Press

Access to resources Recommend Favorite

Metastatic Uterine Papillary Serous Carcinoma to the Pericardium

By Ramirez P.T.   Ramondetta L.M.   Burke T.W.   Gershenson D.M.   Brewer M.A.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 135-137

Elsevier

Access to resources Recommend Favorite

High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up

By Shapiro F.   Schneider J.   Markman M.   Reichman B.S.   Venkatraman E.   Barakat R.   Almadrones L.   Spriggs D.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite